Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005

The Journal of Infectious Diseases
Sandra S ChavesJ F Seward

Abstract

Approximately 1 in every 5 children who receives 1 dose of varicella vaccine may develop varicella disease, also known as breakthrough disease, if exposed to varicella-zoster virus. Currently, in communities with high vaccination coverage, varicella cases mostly occur in vaccinated individuals. We report on the first population-based description of the clinical and epidemiological characteristics of varicella in populations with increasing vaccine coverage between 1997 and 2005. In vaccinated children 1-14 years of age, varicella was most often mild and modified; the atypical disease presentation may result in diagnostic challenges to health care providers. However, despite the generally mild nature of these cases, approximately 25% caused >50 lesions, and some resulted in serious complications similar to those occurring in unvaccinated individuals. Continued surveillance of the risk and characteristics of breakthrough disease will be needed, to monitor the effect of the new 2-dose vaccine recommendation for children.

References

Jun 1, 1992·The Pediatric Infectious Disease Journal·M A JacksonL C Olson
Sep 1, 1995·The Journal of Infectious Diseases·P W ChooR Platt
May 15, 1993·Statistics in Medicine·S E Vollset
Aug 1, 1993·Acta Paediatrica Japonica; Overseas Edition·H NaruseK Yamanishi
Jan 1, 1996·The Pediatric Infectious Disease Journal·A L NgaiC J White
Dec 23, 1999·The Pediatric Infectious Disease Journal·D A ClementsE B Walter
Dec 15, 2000·Vaccine·R G SharrarA A Gershon
Mar 29, 2001·The New England Journal of Medicine·M VázquezE D Shapiro
Feb 7, 2002·JAMA : the Journal of the American Medical Association·Jane F SewardMelinda Wharton
Oct 24, 2002·The Pediatric Infectious Disease Journal·Karin GalilJane Seward
Dec 13, 2002·The New England Journal of Medicine·Karin GalilJane Seward
Feb 12, 2004·The Pediatric Infectious Disease Journal·Barbara KuterUNKNOWN Study Group for Varivax
Mar 3, 2004·Pediatrics·Barna D TugwellPaul R Cieslak
Aug 3, 2004·Pediatrics·Joel Schwab, Matthew Ryan
Feb 4, 2005·The New England Journal of Medicine·Huong Q NguyenJane F Seward
Aug 18, 2005·JAMA : the Journal of the American Medical Association·Fangjun ZhouAbigail Shefer
May 3, 2008·The Journal of Infectious Diseases·Dalya GurisJane F Seward
May 3, 2008·The Journal of Infectious Diseases·Mona MarinJane F Seward

❮ Previous
Next ❯

Citations

Feb 25, 2010·Maternal and Child Health Journal·Susmita PatiAvital Cnaan
Mar 29, 2012·The Journal of Infectious Diseases·Karen C Bloch, James G Johnson
Jan 13, 2010·Clinical Microbiology Reviews·D Scott Schmid, Aisha O Jumaan
Sep 10, 2009·BMC Infectious Diseases·Vincenzo BaldoRenzo Trivello
Dec 12, 2012·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·D Moreno-PérezUNKNOWN Comité Asesor de Vacunas de la Asociación Española de Pediatría, España
Dec 20, 2011·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·D Moreno-PérezUNKNOWN Advisory Committee on Vaccines of the Spanish Association of Pediatrics
Jan 11, 2011·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·J Marès BermúdezUNKNOWN Asociación Española de Pediatría
May 12, 2010·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·J Marès BermúdezUNKNOWN Comité Asesor de Vacunas de la Asociación Española de Pediatría
Apr 8, 2009·International Journal of Nursing Studies·Vladimir GilcaManale Ouakki
Mar 8, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S A PergamUNKNOWN AST Infectious Diseases Community of Practice
Jun 3, 2015·BMJ Case Reports·Celal ŞalçiniAlper Evrensel
Dec 4, 2012·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Julian W Tang
May 20, 2011·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Zafer KurugolSadik Aksit
Mar 5, 2015·Vaccine·Anette SiedlerBernhard Ehlers
Aug 14, 2012·Vaccine·Abdirahman MahamudStephanie R Bialek
Sep 22, 2016·Case Reports in Otolaryngology·Christine M ClarkMichele M Carr
Jun 10, 2011·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Joke BilckeMark Jit
Sep 6, 2018·The Journal of Infectious Diseases·Helen S MarshallUNKNOWN PAEDS Investigators
May 3, 2008·The Journal of Infectious Diseases·Mona MarinJane F Seward
May 3, 2008·The Journal of Infectious Diseases·Rachel CivenLaurene Mascola
Jun 12, 2018·Journal of Public Health Management and Practice : JPHMP·Jessica LeungMona Marin
Mar 10, 2018·Journal of the Pediatric Infectious Diseases Society·Adriana S LopezMona Marin
Jun 5, 2019·Clinical Transplantation·Steven A PergamUNKNOWN AST Infectious Diseases Community of Practice
Jul 25, 2019·Transplantation·Charlotte M VeroletKlara M Posfay-Barbe
Oct 18, 2010·Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada·Alexia CampbellUNKNOWN approved by NACI.
May 23, 2013·The Pediatric Infectious Disease Journal·Johannes G LieseAndrea Streng
Nov 2, 2012·Public Health Reports·Irini DaskalakiBarbara M Watson
Sep 20, 2010·Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada·Ben TanUNKNOWN approved by NACI.
Jun 1, 2012·The Pediatric Infectious Disease Journal·Ben TanUNKNOWN Members of the Canadian Immunization Monitoring Program, Active (IMPACT)
Sep 6, 2018·Journal of Korean Medical Science·Si-Hyun KimDong-Gun Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.